FDA OKs First Biodegradable Implant to Lower IOP FDA OKs First Biodegradable Implant to Lower IOP

Bimatoprost implant (Durysta) delivers 10 µ g of the prostaglandin analog and is an alternative to daily topical eye drops in patients with open-angle glaucoma or ocular hypertension.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news